Alex Waldron

CEO at Wellinks


Alex Waldron is the current CEO of Wellinks. Prior to this, they were a board member at Digital Therapeutics Alliance, where they spearheaded the development of a global brand strategy. Alex also served as the Chief Strategy Officer (CSO) at Pear Therapeutics, where they contributed to significant increases in revenue. In addition, they have served as a business advisor for Platelet BioGenesis and MyoSyntax.

Alex Waldron has a BA in International Business and Economics from Boston University and a Bachelor's degree in Political Science and Government from Boston University.

Some individuals on their team include Ryan McMillan - Chief Financial Officer, Ellen Su - Chief Product Officer, and Geoff Matous - President & Chief Commercial Officer.



  • CEO

    Current role

View in org chart